POST-Covid 19: Clinical Trials

3 trials for POST-Covid 19, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed. 2 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Recruiting 1
Phase 31Recruiting 1

Follow POST-Covid 19: new trials by email Literature Review of POST-Covid 19 trials Research Report on POST-Covid 19

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
sElective Serotonin reuPtake inhibitoRs In posT-covid After COVID-19
Fluvoxamine, Placebo - Post-COVID, POST-Covid 19
Phase 3RecruitingAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1602026-06-042026-06-09
Effects of Hydrotherapy During Post-COVID-19 Rehabilitation
Standard rehabilitation plus cold water hydrotherapy, Standard rehabilitation only - Post-COVID / Long-COVID, POST-Covid 19
Not applicableRecruitingSchön Klinik Berchtesgadener Land502025-08-212025-08-28
Effects of Cranial Electrotherapy Stimulation on Anxiety of Patients After COVID-19
Application of CES via ear clips, Sham: No application of CES via ear clips - POST-Covid 19, Anxiety
Not applicableCompletedSchön Klinik Berchtesgadener Land402021-11-192023-01-12

Narrower conditions

Fatigue (2)  ·  Post-Acute COVID-19 Syndrome (2)  ·  Anxiety Disorders (1)  ·  Sleep Initiation and Maintenance Disorders (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (3)  ·  COVID-19 (2)  ·  Chronic Disease (2)  ·  Coronaviridae Infections (2)  ·  Coronavirus Infections (2)  ·  Disease Attributes (2)  ·  Infections (2)  ·  Lung Diseases (2)  ·  Nidovirales Infections (2)  ·  Pathologic Processes (2)  ·  Pneumonia (2)  ·  Pneumonia, Viral (2)  ·  Post-Infectious Disorders (2)  ·  RNA Virus Infections (2)  ·  Respiratory Tract Diseases (2)

Interventions

Fluvoxamine (1)

Sponsors

Schön Klinik Berchtesgadener Land (2)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)

Countries

Germany (2)  ·  Netherlands (1)

Top investigators

Rembert Koczulla, MD (1)